| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 18,417,000 | 19,924,000 | 22,026,000 | 21,266,000 | | Cost of Revenue | 9,161,000 | 9,565,000 | 10,905,000 | 10,808,000 | | | Gross Profit | 9,256,000 | 10,359,000 | 11,121,000 | 10,458,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,526,000 | 6,224,000 | 6,436,000 | 6,618,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,730,000 | 4,135,000 | 4,685,000 | 3,840,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 93,000 | 90,000 | 337,000 | 67,000 | | Earnings Before Interest And Taxes | 3,823,000 | 4,225,000 | 5,022,000 | 3,907,000 | | Interest Expense | 336,000 | 354,000 | 339,000 | 355,000 | | Income Before Tax | 3,487,000 | 3,871,000 | 4,683,000 | 3,552,000 | | Income Tax Expense | 902,000 | 982,000 | 1,335,000 | 536,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,585,000 | 2,889,000 | 3,348,000 | 3,016,000 | | | Non-recurring Events | | Discontinued Operations | 28,000 | 2,115,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,613,000 | 5,004,000 | 3,348,000 | 3,016,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,613,000 | $5,004,000 | $3,348,000 | $3,016,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
